97 related articles for article (PubMed ID: 23974281)
1. Polymorphisms in the promoter region of estrogen receptor β gene in endometrial cancer.
Lattrich C; Häring J; Schüler S; Skrzypczak M; Ortmann O; Treeck O
Arch Gynecol Obstet; 2014 Mar; 289(3):631-5. PubMed ID: 23974281
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor beta gene polymorphisms and susceptibility to uterine fibroids.
Fischer C; Juhasz-Boess I; Lattrich C; Ortmann O; Treeck O
Gynecol Endocrinol; 2010 Jan; 26(1):4-9. PubMed ID: 19639498
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer.
Schüler S; Lattrich C; Skrzypczak M; Fehm T; Ortmann O; Treeck O
Gene; 2014 Aug; 546(2):283-7. PubMed ID: 24881814
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility.
Treeck O; Elemenler E; Kriener C; Horn F; Springwald A; Hartmann A; Ortmann O
J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):207-11. PubMed ID: 19429453
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta (ESR2 ) polymorphisms and endometrial cancer (United States).
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Causes Control; 2004 Aug; 15(6):627-33. PubMed ID: 15280642
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor polymorphisms and the risk of endometrial cancer.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
[TBL] [Abstract][Full Text] [Related]
7. Significance of rs1271572 in the estrogen receptor beta gene promoter and its correlation with breast cancer in a southwestern Chinese population.
Chen L; Liang Y; Qiu J; Zhang L; Chen X; Luo X; Jiang J
J Biomed Sci; 2013 May; 20(1):32. PubMed ID: 23711151
[TBL] [Abstract][Full Text] [Related]
8. The T/C polymorphism of the CYP17 gene and G/A polymorphism of the CYP19 gene in endometrial cancer.
Szyllo K; Smolarz B; Romanowicz-Makowska H; Lewy J; Kulig B
J Exp Clin Cancer Res; 2006 Sep; 25(3):411-6. PubMed ID: 17167982
[TBL] [Abstract][Full Text] [Related]
9. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of estrogen receptor alpha gene in endometrial cancer.
Sasaki M; Tanaka Y; Kaneuchi M; Sakuragi N; Dahiya R
Biochem Biophys Res Commun; 2002 Sep; 297(3):558-64. PubMed ID: 12270131
[TBL] [Abstract][Full Text] [Related]
11. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
[TBL] [Abstract][Full Text] [Related]
12. Association of CYP1B1 gene polymorphisms and the positive expression of estrogen alpha and estrogen beta with endometrial cancer risk.
Zhu ZY; Mu YQ; Fu XM; Li SM; Zhao FX
Eur J Gynaecol Oncol; 2011; 32(2):188-91. PubMed ID: 21614911
[TBL] [Abstract][Full Text] [Related]
13. Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.
Setiawan VW; Doherty JA; Shu XO; Akbari MR; Chen C; De Vivo I; Demichele A; Garcia-Closas M; Goodman MT; Haiman CA; Hankinson SE; Henderson BE; Horn-Ross PL; Lacey JV; Le Marchand L; Levine DA; Liang X; Lissowska J; Lurie G; McGrath M; Narod SA; Rebbeck TR; Ursin G; Weiss NS; Xiang YB; Yang HP; Zheng W; Olson SH
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):242-7. PubMed ID: 19124504
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
[TBL] [Abstract][Full Text] [Related]
15. SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers.
Okamoto K; Tsunematsu R; Tahira T; Sonoda K; Asanoma K; Yagi H; Yoneda T; Hayashi K; Wake N; Kato K
BMC Med Genet; 2015 Aug; 16():67. PubMed ID: 26293665
[TBL] [Abstract][Full Text] [Related]
16. No association between estrogen receptor beta polymorphisms and uterine leiomyoma.
Zhai XD; Ye Y; Yang Y; Wang Z; Mo YN
DNA Cell Biol; 2009 Dec; 28(12):633-6. PubMed ID: 19715484
[TBL] [Abstract][Full Text] [Related]
17. Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women.
Passarelli MN; Phipps AI; Potter JD; Makar KW; Coghill AE; Wernli KJ; White E; Chan AT; Hutter CM; Peters U; Newcomb PA
Cancer Res; 2013 Jan; 73(2):767-75. PubMed ID: 23149914
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Cancer Causes Control; 2009 Feb; 20(1):47-55. PubMed ID: 18704709
[TBL] [Abstract][Full Text] [Related]
19. Association of estrogen receptor-beta (ESR2) polymorphism and cancer risk: a meta-analysis.
Xia W; Wang T; Sun D; Mao W; Xie X
Eur J Gynaecol Oncol; 2016 Aug; 37(4):530-538. PubMed ID: 29894079
[TBL] [Abstract][Full Text] [Related]
20. Impact of
Helwa R; Gansmo LB; Bjørnslett M; Halle MK; Werner HMJ; Romundstad P; Hveem K; Vatten L; Dørum A; Lønning PE; Knappskog S
Biomarkers; 2021 Jun; 26(4):302-308. PubMed ID: 33645339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
